Brain metabolic alterations in medication-free patients with bipolar disorder.
暂无分享,去创建一个
In Kyoon Lyoo | A. Stoll | P. Renshaw | S. Dager | S. Friedman | D. Dunner | I. Lyoo | C. Demopulos | A. Parow | Perry F Renshaw | David L Dunner | Seth D Friedman | Andrew L Stoll | Stephen R Dager | Aimee Parow | Christina Demopulos | Aimee M. Parow
[1] N. Kato,et al. Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders , 1998, European Archives of Psychiatry and Clinical Neuroscience.
[2] T. Crawford,et al. Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. , 2003, AJNR. American journal of neuroradiology.
[3] G. Bartzokis,et al. An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia , 2000, Biological Psychiatry.
[4] R. Bland. Epidemiology of Affective Disorders: A Review , 1997, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[5] R G Shulman,et al. Cerebral energetics and the glycogen shunt: Neurochemical basis of functional imaging , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[6] J. Barendregt,et al. Global burden of disease , 1997, The Lancet.
[7] K. Krishnan,et al. Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders. , 1996, Depression.
[8] D. Dunner. Sub-types of bipolar affective disorder with particular regard to bipolar II. , 1983, Psychiatric developments.
[9] J C Mazziotta,et al. Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. , 1985, Archives of general psychiatry.
[10] E. Adalsteinsson,et al. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder , 1998, Biological Psychiatry.
[11] Bernadette Lipinski,et al. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study , 2000, Biological Psychiatry.
[12] Stephen M Strakowski,et al. Volumetric MRI studies of mood disorders: do they distinguish unipolar and bipolar disorder? , 2002, Bipolar disorders.
[13] K. Krishnan,et al. Brain choline in depression: In vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy , 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[14] T. Inubushi,et al. Measurement of brain phosphoinositide metabolism in bipolar patients using in vivo 31P-MRS. , 1991, Journal of affective disorders.
[15] T. Inubushi,et al. Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. , 1994, Journal of affective disorders.
[16] D. Dunner. A review of the diagnostic status of “Bipolar II” for the DSM‐IV work group on mood disorders , 1993 .
[17] K O Lim,et al. In vivo spectroscopic quantification of the N‐acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: Effects of normal aging , 1999, Magnetic resonance in medicine.
[18] A. Stoll,et al. Basal ganglia choline levels in depression and response to fluoxetine treatment: An in vivo proton magnetic resonance spectroscopy study , 1997, Biological Psychiatry.
[19] J. Blusztajn,et al. Acceleration of phosphatidylcholine synthesis and breakdown by inhibitors of mitochondrial function in neuronal cells: a model of the membrane defect of Alzheimer's disease. , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] N. Kato,et al. Mitochondrial DNA polymorphisms in bipolar disorder. , 2001, Journal of affective disorders.
[21] L. Altshuler,et al. MRI-based measurements of temporal lobe and ventricular structures in patients with bipolar I and bipolar II disorders. , 2000, Journal of affective disorders.
[22] T. Richards,et al. Single-voxel 1H-MRS investigation of brain metabolic changes during lactate-induced panic , 1997, Psychiatry Research: Neuroimaging.
[23] S. Strakowski,et al. Regional prefrontal gray and white matter abnormalities in bipolar disorder , 2002, Biological Psychiatry.
[24] R. Wyatt,et al. An economic evaluation of manic-depressive illness-1991 , 1995, Social Psychiatry and Psychiatric Epidemiology.
[25] M. Castillo,et al. Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations. , 2000, AJNR. American journal of neuroradiology.
[26] H. Manji,et al. Signaling: cellular insights into the pathophysiology of bipolar disorder , 2000, Biological Psychiatry.
[27] G. Moore,et al. Lithium-induced increase in human brain grey matter , 2000, The Lancet.
[28] D. Dunner,et al. Optimizing lithium treatment. , 2000, The Journal of clinical psychiatry.
[29] G. Moore,et al. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic–depressive illness , 2000, Biological Psychiatry.
[30] Stefan Riehemann,et al. 31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients , 1998, European Archives of Psychiatry and Clinical Neuroscience.
[31] M. Frye,et al. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder , 2001, Biological Psychiatry.
[32] D. Braus,et al. The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. , 2000, Archives of general psychiatry.
[33] V. Calabrese,et al. Mitochondrial Involvement in Brain Function and Dysfunction: Relevance to Aging, Neurodegenerative Disorders and Longevity , 2001, Neurochemical Research.
[34] P. Renshaw,et al. Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy , 2000, Biological Psychiatry.
[35] P. Renshaw,et al. Ethanolamine and phosphoethanolamine inhibit mitochondrial function in vitro: implications for mitochondrial dysfunction hypothesis in depression and bipolar disorder , 2004, Biological Psychiatry.
[36] C Yuan,et al. In vivo measurement of regional brain metabolic response to hyperventilation using magnetic resonance: Proton echo planar spectroscopic imaging (PEPSI) , 1997, Magnetic resonance in medicine.
[37] G. Migliorati,et al. Exogenous Phospholipids Specifically Affect Transmembrane Potential of Brain Mitochondria and Cytochrome cRelease* , 2002, The Journal of Biological Chemistry.
[38] K. O Lim,et al. Cortical gray matter deficit in patients with bipolar disorder , 1999, Schizophrenia Research.
[39] S. Dager,et al. Applications of magnetic resonance spectroscopy to the investigation of neuropsychiatric disorders. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[40] W M Brooks,et al. Reproducibility of 1H‐MRS in vivo , 1999, Magnetic resonance in medicine.
[41] P. Marsden,et al. Lactate: A Preferred Fuel for Human Brain Metabolism in Vivo , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[42] N. Kato,et al. Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: a confirmation in drug-free patients and correlation with white matter hyperintensity , 1998, European Archives of Psychiatry and Clinical Neuroscience.
[43] N. Kato,et al. Mitochondrial dysfunction in bipolar disorder. , 2000, Bipolar disorders.
[44] A. Stoll,et al. Frontal lobe gray matter density decreases in bipolar I disorder , 2004, Biological Psychiatry.
[45] P. Renshaw,et al. 31P Nuclear magnetic resonance spectroscopy findings in bipolar illness: a meta-analysis , 2001, Psychiatry Research: Neuroimaging.
[46] S. Posse,et al. Two-dimensional proton echo-planar spectroscopic imaging of brain metabolic changes during lactate-induced panic. , 1999, Archives of general psychiatry.
[47] N. Kato,et al. Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder , 1999, Psychological Medicine.
[48] D. Kupfer,et al. Increased gray matter volume in lithium-treated bipolar disorder patients , 2002, Neuroscience Letters.
[49] R. Langevin,et al. Deficits in gray matter volume are present in schizophrenia but not bipolar disorder 1 This work was presented at the Meeting of the Society of Biological Psychiatry, Philadelphia, PA, USA, May 1994. 1 , 1997, Schizophrenia Research.
[50] Guang Chen,et al. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2’s neurotrophic effects? , 2000, Biological Psychiatry.
[51] R. Bullock,et al. Induced mitochondrial failure in the feline brain: implications for understanding acute post-traumatic metabolic events , 2001, Brain Research.
[52] R. Feiwell,et al. Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. , 2003, The American journal of psychiatry.
[53] P. Keck,et al. Outcome in the Pharmacologic Treatment of Bipolar Disorder , 1996, Journal of clinical psychopharmacology.
[54] Peter Lipton,et al. Do active cerebral neurons really use lactate rather than glucose? , 2001, Trends in Neurosciences.
[55] K. Lim,et al. Estimating NAA in cortical gray matter with applications for measuring changes due to aging , 1997, Magnetic resonance in medicine.
[56] M. Raichle,et al. A functional anatomical study of unipolar depression , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[57] M. Hamilton. A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.
[58] Yvette I. Sheline,et al. Amygdala core nuclei volumes are decreased in recurrent major depression , 1998, Neuroreport.
[59] Y. Yonekawa,et al. Changes in major phospholipids of mitochondria during postischemic reperfusion in rat brain. , 1992, Journal of neurosurgery.
[60] S. Strakowski,et al. Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. , 1999, Archives of general psychiatry.
[61] S. Strakowski,et al. Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. , 2002, Bipolar disorders.
[62] G. Dienel,et al. Glucose and lactate metabolism during brain activation , 2001, Journal of neuroscience research.
[63] R. C. Young,et al. A Rating Scale for Mania: Reliability, Validity and Sensitivity , 1978, British Journal of Psychiatry.
[64] T. Richards,et al. Preliminary application of magnetic resonance spectroscopy to investigate lactate-induced panic. , 1994, The American journal of psychiatry.
[65] C. Bowden. Efficacy of lithium in mania and maintenance therapy of bipolar disorder. , 2000, The Journal of clinical psychiatry.
[66] M. Raichle,et al. Subgenual prefrontal cortex abnormalities in mood disorders , 1997, Nature.
[67] P F Renshaw,et al. Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study. , 1997, The American journal of psychiatry.
[68] F. Goodwin. Manic-Depressive Illness , 1990 .
[69] M. Weissman,et al. Cross-national epidemiology of major depression and bipolar disorder. , 1996, JAMA.
[70] M. Fava,et al. Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine. , 1999, The American journal of psychiatry.
[71] S. Posse,et al. Modeling brain compartmental lactate response to metabolic challenge: a feasibility study , 2000, Psychiatry Research: Neuroimaging.
[72] G. Dawson,et al. Regional brain chemical alterations in young children with autism spectrum disorder , 2003, Neurology.
[73] S. Provencher. Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.
[74] J. Mazziotta,et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. , 1989, Archives of general psychiatry.
[75] Dunner Dl. Sub-types of bipolar affective disorder with particular regard to bipolar II , 1983 .
[76] J. Clark,et al. N-Acetyl Aspartate: A Marker for Neuronal Loss or Mitochondrial Dysfunction , 1998, Developmental Neuroscience.
[77] P. Narayana,et al. Relative Concentrations of Proton MR Visible Neurochemicals in Gray and White Matter in Human Brain , 1995, Magnetic resonance in medicine.
[78] B J Soher,et al. Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference , 1993, NMR in biomedicine.
[79] Allan Reiss,et al. Decreased N-Acetylaspartate in children with familial bipolar disorder , 2003, Biological Psychiatry.
[80] T. Ketter,et al. 74. Decreased dorsolateral prefrontal n-acetyl aspartate in bipolar disorder , 1998, Biological Psychiatry.
[81] Y. Okada,et al. Effect of lactate on the synaptic potential, energy metabolism, calcium homeostasis and extracellular glutamate concentration in the dentate gyrus of the hippocampus from guinea-pig , 2001, Neuroscience.
[82] P. Renshaw,et al. Magnetic resonance spectroscopy: current and future applications in psychiatric research , 2002, Biological Psychiatry.
[83] P. Magistretti,et al. Metabolic coupling between glia and neurons , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[84] D P Auer,et al. On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain , 1995, NMR in biomedicine.